SAM
ALDR

Senzar Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Senzar Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-85,558
Closed -$1.35M – 24
2018
Q2 		$1.35M Sell
85,558
-737,332
-90% -$11.2M 3.9% 11
2018
Q1 		$10.5M Buy
822,890
+36,020
+5% +$521K 3.3% 11
2017
Q4 		$9.01M Buy
786,870
+145,700
+23% +$1.63M 2.3% 17
2017
Q3 		$7.85M Buy
641,170
+83,400
+15% +$870K 1.92% 16
2017
Q2 		$6.39M Buy
557,770
+342,700
+159% +$6.34M 1.57% 16
2017
Q1 		$4.47M Buy
215,070
+90,500
+73% +$2M 1.13% 23
2016
Q4 		$2.59M Sell
124,570
-172,100
-58% -$4.48M 0.69% 25
2016
Q3 		$9.72M Sell
296,670
-42,400
-13% -$1.29M 2.51% 16
2016
Q2 		$8.47M Sell
339,070
-174,500
-34% -$4.72M 1.84% 18
2016
Q1 		$12.6M Sell
513,570
-43,600
-8% -$1.01M 2.5% 13
2015
Q4 		$18.4M Buy
557,170
+7,270
+1% +$246K 2.05% 16
2015
Q3 		$18M Buy
+549,900
New +$23.4M 2.62% 13

Other funds holding ALDR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Senzar Asset Management's ALDR Position: Q3 2018 in Review

Senzar Asset Management sold out of Alder Biopharmaceuticals (ALDR) in Q3 2018, closing a stake of 85,558 shares — an estimated $1.35M sold.

Senzar Asset Management first reported a position in ALDR in Q3 2015 and held it in 12 quarters. The position peaked at $18.4M in Q4 2015. 128 funds tracked by Wall St. Rank hold ALDR as of Q3 2018.

  • Senzar Asset Management reported no remaining Alder Biopharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Senzar Asset Management sold 85,558 Alder Biopharmaceuticals shares in Q3 2018, an estimated $1.35M.
  • Senzar Asset Management first reported a position in Alder Biopharmaceuticals in Q3 2015 and held it in 12 quarters.
  • Senzar Asset Management's Alder Biopharmaceuticals position peaked at $18.4M in Q4 2015.
  • 128 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2018.

Based on Senzar Asset Management's 13F filing for Q3 2018.